In-depth Analysis of Folic Acid Market Development Trends, 2026–2030
叶酸市场前景
In-depth Analysis of Folic Acid Market Development Trends, 2026–2030
Against the backdrop of continuous upgrading of the global health industry and the growing popularity of precision nutrition concepts, folic acid, a critical water-soluble B vitamin, is undergoing a profound transformation from basic nutritional supplementation toward high-value, functional and precision-oriented applications. From 2026 to 2030, the global folic acid market (including folic acid powder) will witness steady growth alongside structural shifts, driven by the combined effects of policy incentives, rising consumer demand and technological innovation.
In terms of market size, the global folic acid market reached approximately USD 770–880 million in 2025, and is projected to expand to USD 810–1,050 million by 2026, with an annual growth rate ranging from 5% to 10%. Looking ahead to 2030, the market size is expected to exceed USD 1.3 billion, representing a compound annual growth rate (CAGR) of roughly 6.09% from 2026 to 2034. Notably, powder formulations rank as the second-largest product form after tablets, accounting for 25% to 30% of total market share. With a CAGR of around 7.5%, powders register the fastest growth among all dosage forms, far outpacing the industry average. This trend stems from the unique merits of powders in flexible formulation, enhanced bioavailability and multi-scenario applicability, with robust demand particularly for multivitamin powders, meal replacements, solid beverages and foods for special medical purposes (FSMP).
Multiple powerful core factors fuel market expansion. First and foremost, maternal and prenatal health remains an irreplaceable fundamental driver of folic acid demand. Over 50 countries worldwide have enforced mandatory folic acid fortification of flour, with the UK, India, Australia and other nations set to roll out relevant policies successively between 2026 and 2027. China’s National Nutrition Program continuously promotes folic acid supplementation for women before conception and in early pregnancy, supporting steady penetration and forming a stable fundamental market base. Second, rising awareness of cardiovascular and cerebrovascular health among the elderly has unlocked new growth opportunities. Combined intake of folic acid with vitamin B6 and B12 effectively lowers homocysteine levels and prevents chronic illnesses such as cerebral infarction and myocardial infarction. As population aging accelerates, demand for this application segment is surging rapidly. Furthermore, the expansion of dietary supplements and functional foods has created broad prospects for folic acid powder, with gradual market penetration emerging in emerging sectors including sports nutrition and pet feed.
More importantly, the rise of active folic acid, namely 5-methyltetrahydrofolate (5-MTHF), is reshaping the overall market landscape. Around 30% of the Chinese population carries the MTHFR gene mutation, which impairs the metabolic efficiency of conventional folic acid. In contrast, active folic acid can be directly absorbed and utilized by the human body without metabolic conversion, delivering superior bioavailability and safety profiles. These advantages make it highly sought-after in premium dietary supplements, prenatal nutrition products and chronic disease management solutions, achieving a projected CAGR of approximately 15% — far exceeding that of regular folic acid. The adoption of high-purification, micronization and nano-encapsulation technologies further improves the stability and absorption efficiency of active folic acid powder, driving product upgrades toward pharmaceutical-grade specifications with purity ≥98%, while the market share of feed-grade variants gradually declines.
By application segment, dietary supplements constitute the largest end-use sector, capturing 40% to 45% of market volume, primarily covering multivitamin blends, prenatal formulas and auxiliary preparations for cardiovascular health. Food fortification stands as the fastest-growing track with a CAGR of roughly 8%, widely adopted in flour, cereals, dairy products and functional beverages. The pharmaceutical sector maintains stable growth, with folic acid applied mainly for the treatment of megaloblastic anemia and adjuvant therapy for chronic diseases. The feed market exhibits steady demand, focused on boosting reproductive performance and offspring survival rates of livestock and poultry.
In terms of competitive landscape, China dominates the global folic acid supply chain, accounting for over 65% of total global production capacity. Domestic manufacturers including Zhejiang Medicine, North China Pharmaceutical and Yichang Dongyangguang are major global suppliers by virtue of cost and technological advantages. International giants such as BASF, DSM and Merck control the high-end overseas market. Going forward, rising technical barriers for active folic acid and tightening regulatory oversight will further boost industry concentration. Enterprises with robust R&D capabilities and full industrial chain layout will gain greater market influence.
In summary, the global folic acid market will enter a new phase of high-quality development from 2026 to 2030, propelled by three major growth drivers: rigid fundamental demand, consumption upgrading and technological innovation. Folic acid powder and active folic acid will serve as the dual engines of market expansion, while Chinese manufacturers will continue to consolidate and elevate their standing within the global value chain.
